Back to today’s briefing

Story perspectives

Study Reveals Cost Barriers in NSCLC Treatment Strategies

1/19/2025

50 5

Summary

Story summary

A recent study in the Journal of Managed Care & Specialty Pharmacy reveals the financial hurdles faced in treating non-small cell lung cancer (NSCLC). By examining 237 cost-effectiveness models, researchers uncovered stark differences in treatment evaluations. They stress the importance of following best practices and utilizing open-source models to enhance resource distribution and improve patient care in NSCLC.

1 of 1

Story summary

A recent study in the Journal of Managed Care & Specialty Pharmacy reveals the financial hurdles faced in treating non-small cell lung cancer (NSCLC). By examining 237 cost-effectiveness models, researchers uncovered stark differences in treatment evaluations. They stress the importance of following best practices and utilizing open-source models to enhance resource distribution and improve patient care in NSCLC.